» Articles » PMID: 22769861

Migraine Diagnosis: Screening Items, Instruments, and Scales

Overview
Specialty Anesthesiology
Date 2012 Jul 10
PMID 22769861
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is a common and disabling disorder with a 1-year prevalence of 4.5-6% in men and 14.5-18% in women. The diagnosis of migraine is usually made according to the second edition of the International Classification of Headache Disorders (ICHD-2) criteria; however, not all physicians are familiar with the diagnostic criteria. Underdiagnosis remains a major issue in general practice, resulting in inadequate treatment. Several instruments are designed to improve the diagnosis of migraine, to identify the comorbid psychological disturbances, to measure the burden and disability, and to access any reduction in quality of life (QoL) that occurs due to migraine attacks with good reliability and validity. Furthermore, the disability and QoL measured by certain instruments serve as surrogate targets when treating migraines. In this review, we examine the instruments that are in common use in daily practice and current research on migraines, focusing on the purpose of each instrument, clinical applications, pitfalls in interpretation, and, if any, minimally clinically important difference(s) (MCID). In general, a structured intake form and a headache diary are recommended in approaching patients with headache. In addition, ID-Migraine, a three-item screening test, has been validated in primary care settings as a way to improve the rapid diagnosis of migraine. The Visual Aura Rating Scale (VARS) is helpful for the diagnosis of migraine with aura. In addition, migraine is commonly associated with psychiatric comorbidities, which can be assessed by the Beck Depression Inventory (BDI), 9-item Patient Health Questionnaire (PHQ-9), and Hospital Anxiety and Depression Scale (HADS). To evaluate the impact of migraines, disability can be assessed using the Migraine Disability Assessment Questionnaire (MIDAS). Reduction in QoL can be evaluated using the Migraine-Specific Quality of Life Survey (MSQ 2.1), European Quality of Life-Five Dimensions (EQ-5D), or Short-Form 36 (SF-36). Despite all these instruments, proper selection and interpretation of each instrument remain crucial.

Citing Articles

Low health literacy impact on headache diagnosis.

Pergolizzi Jr J, LeQuang J Pain Manag. 2025; 15(3):141-147.

PMID: 39987468 PMC: 11881871. DOI: 10.1080/17581869.2025.2463874.


Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: a randomized control trial.

Deodato M, Granato A, Buoite Stella A, Martini M, Marchetti E, Lise I Neurol Sci. 2024; 45(8):4015-4026.

PMID: 38806882 PMC: 11255006. DOI: 10.1007/s10072-024-07611-8.


Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study.

Marino A, Currado D, Altamura C, Vomero M, Berardicurti O, Corberi E Biomedicines. 2024; 12(2).

PMID: 38397972 PMC: 10886921. DOI: 10.3390/biomedicines12020371.


Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review.

Rhyne C, Cohen J, Seminerio M, Carr K, Krasenbaum L Medicine (Baltimore). 2023; 102(23):e33874.

PMID: 37335663 PMC: 10256346. DOI: 10.1097/MD.0000000000033874.


Migraine and Current Pharmacologic Management.

Okobi O, Boms M, Ijeh J, Eboigbe S, Alex K, Adejola A Cureus. 2022; 14(10):e29833.

PMID: 36337819 PMC: 9626373. DOI: 10.7759/cureus.29833.